Corroborating evidence for platelet-induced epithelial-mesenchymal transition and fibroblast-to-myofibroblast transdifferentiation in the development of adenomyosis
The DOI matches its Crossref record; 99 of the 99 references it cites were found in a registry or an index.
Abstract
STUDY QUESTION: Do platelets play any role in the development of adenomyosis? SUMMARY ANSWER: As in endometriosis, adenomyotic lesions show significantly increased platelet aggregation, increased expression of transforming growth factor (TGF)-β1, phosphorylated Smad3, markers of epithelial-mesenchymal transition (EMT) and fibroblast-to-myofibroblast transdifferentiation (FMT), and smooth muscle metaplasia (SMM), in conjunction with increased fibrosis as compared with normal endometrium. WHAT IS KNOWN ALREADY: Both EMT and FMT are known to play vital roles in fibrogenesis in general and in endometriosis in particular. EMT has been implicated in the development of adenomyosis. SMM is universally seen in endometriosis and also in adenomyosis, and is correlated positively with the extent of fibrosis. However, there has been no published study on the role of platelets in fibrogenesis in adenomyosis, even though adenomyotic lesions undergo repeated cycles of tissue injury and repair, which suggests the involvement of platelets and their possible roles in fibrogenesis. STUDY DESIGN, SIZE, DURATION: Cross-sectional studies of ectopic endometrial and control endometrial tissue samples from three sets of women with and without adenomyosis (n= 34 and 20, 12 and 10, and 8 and 8, respectively) were carried out from 2014 to 2015. PARTICIPANTS/MATERIALS, SETTING, METHODS: Immunohistochemistry analysis of ectopic endometrial tissues from women with (n= 34) and without (n= 20) adenomyosis with respect to biomarkers of EMT, FMT and highly differentiated smooth muscle cells as well as TGF-β1, phosphorylated Smad3, markers of proliferation, angiogenesis and extracellular matrix (ECM) deposits. Masson trichrome staining, Van Gieson staining and Pico-Sirius staining were performed to evaluate and quantify the extent of fibrosis in lesions. Progesterone receptor isoform B (PR-B) staining also was performed. In addition, CD42b-positive platelets in ectopic (n= 12) and control (n= 10) endometrium were counted by confocal microscopy and compared. The protein expression levels of TGF-β1 and phosphorylated Smad3 in both ectopic (n= 8) and control (n= 8) endometrium were measured by western blot analysis. Immunofluorescent staining of both platelets and hepatocyte growth factor (HGF) was also performed for adenomyotic tissue samples (n= 10). MAIN RESULTS AND THE ROLE OF CHANCE: Adenomyotic lesions had a significantly higher extent of platelet aggregation and increased staining for TGF-β1 and phosphorylated Smad3 (both P-values <0.001 versus control). In addition, E-cadherin staining was decreased while vimentin staining in adenomyotic epithelial cells was increased, along with increased staining of proliferating cell nuclear antigen, vascular endothelial growth factor and CD31 (all P-values <0.001), markers of proliferation and angiogenesis. Staining for α-SMA, a marker for myofibroblast, desmin, smooth muscle myosin heavy chain and oxytocin receptor was significantly increased in adenomyotic lesions versus control, concomitant with increased staining of collagen I and lysyl oxidase (all P-values <0.001). Histochemistry analysis indicates that the extent of fibrosis is high in adenomyotic lesions (P < 0.001), and the extent appeared to correlate negatively with the microvessel density (P < 0.05). PR-B staining was significantly decreased in adenomyotic lesion as compared with control endometrium (P < 0.001). Platelets and HGF were co-localized mostly in the stromal component of adenomyotic lesions, near the glandular epithelium. LIMITATIONS, REASONS FOR CAUTION: The results are limited by the cross-sectional nature of the study and the use of histochemistry and immunohistochemistry analyses only, but nonetheless is a validation of our previous finding in mouse experiments. WIDER IMPLICATIONS OF THE FINDINGS: The data presented are consistent with the notion that platelet-induced activation of the TGF-β/Smad signaling pathway may be a driving force in EMT, FMT and SMM in the development of adenomyosis, leading to fibrosis. This study provides the first piece of evidence that adenomyotic lesions are wounds that undergo repeated injury and healing, and, as such, platelets play critical roles in the development of adenomyosis by promoting proliferation, angiogenesis, increasing ECM deposits, and SMM, resulting in fibrosis. Platelets may also be involved in uterine hyperactivity and myometrial hyperinnervation. Our results provide one explanation as to why adenomyosis is a challenge for medical treatment, and shed new light onto the pathophysiology of adenomyosis. STUDY FUNDING/COMPETING INTERESTS: Support for data collection and analysis was provided by grants from the National Science Foundation of China. None of the authors has anything to disclose.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Since the extent of lesional fibrosis is a proxy for lesional developmental stage (Guo et al., 2015; Liu et al., 2016; Shen et al., 2016; Zhang et al., 2016)”
From Progressively diminished estrogen signaling concordant with increased fibrosis in ectopic endometrium (2025) · cites this paper as Liu et al., 2016
In the citing paper
“As adenomyosis shares with endometriosis in cyclic bleeding and thus ReTIAR, the two diseases also share common key molecular events in lesional development, i.e., EMT, fibroblast-to-myofibroblast transdifferentation, smooth muscle metaplasia, and fibrogenesis [105,106].”
From The Pathogenesis of Adenomyosis vis-à-vis Endometriosis (2020) · cites this paper as [105]
In the citing paper
“regardless of subtypes, all endometriotic lesions appear to undergo identical molecular processes such as epithelial-mesenchymal transition (EMT), fibroblast-to-myofibroblast transdifferentiation (FMT), smooth muscle metaplasia (SMM), and fibrogenesis25,26,53, even in adenomyotic lesions81,82.”
From Platelets induce increased estrogen production through NF-κB and TGF-β1 signaling pathways in endometriotic stromal cells (2020) · cites this paper as [81]
In the citing paper
“As a corollary, OE and DE, and likely other subtypes of endometriosis and adenomyosis as well91,92, have the identical pathophysiology and similar natural history as wounds undergoing ReTIAR.”
From Neuropeptides Substance P and Calcitonin Gene Related Peptide Accelerate the Development and Fibrogenesis of Endometriosis (2019) · cites this paper as [91]
Citations
Cites
David, F. N., & Tukey, J. W. (1977) · Biometrics · doi:10.2307/2529486 · Cited by 12,708
R: A Language for Data Analysis and Graphics
Ihaka, R., & Gentleman, R. (1996) · Journal of Computational and Graphical Statistics · doi:10.1080/10618600.1996.10474713 · Cited by 11,220
Epithelial-Mesenchymal Transitions in Development and Disease
Thiery, J. P., Acloque, H., Huang, R. Y. J., & Nieto, M. A. (2009) · Cell · doi:10.1016/j.cell.2009.11.007 · Cited by 9,931 · cited 3×
“In addition, while EMT is known to occur in tissue repair (Thiery et al., 2009) and often leads to fibrosis (Nawshad et al., 2004), it is unclear whether fibrosis also is present in adenomyosis as in endometriosis (Matsuzaki and Darcha, 2013).”
BackgroundR: A Language for Data Analysis and Graphics
Ihaka, R., & Gentleman, R. C. (1996) · Journal of Computational and Graphical Statistics · doi:10.2307/1390807 · Cited by 4,245
Formation and function of the myofibroblast during tissue repair
Hinz, B. (2007) · Journal of Investigative Dermatology · doi:10.1038/sj.jid.5700613 · Cited by 1,658 · cited 1×
“It also involves myofibroblast activation so that fibroblasts acquire a migratory phenotype in order to re-populate the damaged tissues (Hinz, 2007).”
BackgroundCommon and unique mechanisms regulate fibrosis in various fibroproliferative diseases
Wynn, T. A. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31487 · Cited by 1,456 · cited 2×
“However, with repeated and persistent tissue injury and then repair, the normal, physiological wound-healing response can go awry (Wynn, 2007), resulting in excessive ECM deposits, leading to fibrosis (Thannickal et al., 2014).”
BackgroundCoppinger, J. A., Cagney, G., Toomey, S., Kislinger, T., Belton, O., McRedmond, J. P., Cahill, D. J., Emili, A., Fitzgerald, D. J., & Maguire, P. B. (2004) · Blood · doi:10.1182/blood-2003-08-2804 · Cited by 814 · cited 4×
“Following platelet activation, hundreds of biologically active molecules, including HGF (Nakamura et al., 1986; Matsuo et al., 2008), are released and deposited at the sites of a wound (Coppinger et al., 2004) and, as shown in Fig.”
BackgroundInfluentialNeutrophils scan for activated platelets to initiate inflammation
Sreeramkumar, V., Adrover, J. M., Ballesteros, I., Cuartero, M. I., Rossaint, J., Bilbao, I., Nácher, M., Pitaval, C., Radovanovic, I., Fukui, Y., et al. (2014) · Science · doi:10.1126/science.1256478 · Cited by 650 · cited 1×
“Activated platelets were found to play a critical role in initiating inflammation (Sreeramkumar et al., 2014).”
BackgroundNakamura, T., Teramoto, H., & Ichihara, A. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.17.6489 · Cited by 582 · cited 2×
“Following platelet activation, hundreds of biologically active molecules, including HGF (Nakamura et al., 1986; Matsuo et al., 2008), are released and deposited at the sites of a wound (Coppinger et al.”
BackgroundPathology and physiopathology of adenomyosis
Bergeron, C., Amant, F., & Ferenczy, A. (2006) · Best Practice & Research Clinical Obstetrics & Gynaecology · doi:10.1016/j.bpobgyn.2006.01.016 · Cited by 359 · cited 3×
“Treatment of adenomyosis is challenging, with hysterectomy being the treatment of choice (Bergeron et al., 2006).”
BackgroundPitfalls in the Measurement of Circulating Vascular Endothelial Growth Factor
Jelkmann, W. (2001) · Clinical Chemistry · doi:10.1093/clinchem/47.4.617 · Cited by 322 · cited 1×
“In some cancers in particular, platelet-derived VEGF better predicts tumor progression than serum levels of VEGF (Jelkmann, 2001).”
BackgroundKitawaki, J., Noguchi, T., Amatsu, T., Maeda, K., Tsukamoto, K., Yamamoto, T., Fushiki, S., Osawa, Y., & Honjo, H. (1997) · Biology of Reproduction · doi:10.1095/biolreprod57.3.514 · Cited by 305 · cited 2×
“…from https://academic.oup.com/humrep/article-abstract/31/4/734/2380144 by guest on 26 July 2018 Adenomyosis has been traditionally viewed as an estrogen-dependent disorder (Kitawaki, 2006), featuring aberrant expression of aromatase and increased production of estrogens (Kitawaki et al., 1997).”
BackgroundChambers, R. C., Leoni, P., Kaminski, N., Laurent, G. J., & Heller, R. A. (2003) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63847-3 · Cited by 255 · cited 12×
“…one gene expression profiling study reports thatafter just 36 h of exposure to TGF-b1, human fetal lung fibroblasts expressed caldesmon and SM-MHC (Chambers et al., 2003), markers that are thought to be reserved for differentiated SMC. Similarly, corneal fibroblasts with extended exposure to…”
BackgroundInfluentialIsolation, characterization, and comparison of human endometrial and endometriosis cells in vitro
Ryan, I. P. (1994) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.78.3.642 · Cited by 248 · cited 1×
“The isolationand culture of adenomyosis-derivedprimaryectopic endometrial stromal cells (EESC) and normal endometrial stromal cells (NESC) derived from control endometrial tissues were carried out as reported previously (Ryan et al., 1994).”
ResultStructural and molecular features of the endomyometrium in endometriosis and adenomyosis
Benagiano, G., Brosens, I., & Habiba, M. (2014) · Human Reproduction Update · doi:10.1093/humupd/dmt052 · Cited by 246 · cited 2×
“It is also recognized as an inflammatory disease, as characterized by increased production/expression of proinflammatory cytokines and chemokines (Ulukus et al., 2005, 2006; Benagiano et al., 2014) and the constitutive activation of nuclear factor-kB (Li et al.”
BackgroundChen, Y., Li, H., Huang, C., Twu, N., Yen, M., Wang, P., Chou, T., Liu, Y., Chao, K., & Yang, M. (2010) · The Journal of Pathology · doi:10.1002/path.2761 · Cited by 245 · cited 4×
“and increase in vimentin expression is consistent with reported EMT in adenomyosis (Chen et al., 2010; Khan et al., 2015).”
BackgroundResultInfluentialFibrosis: ultimate and proximate causes
Thannickal, V. J., Zhou, Y., Gaggar, A., & Duncan, S. R. (2014) · Journal of Clinical Investigation · doi:10.1172/jci74368 · Cited by 242 · cited 1×
“However, with repeated and persistent tissue injury and then repair, the normal, physiological wound-healing response can go awry (Wynn, 2007), resulting in excessive ECM deposits, leading to fibrosis (Thannickal et al., 2014).”
BackgroundThe pathophysiology of uterine adenomyosis: an update
Benagiano, G., Habiba, M., & Brosens, I. (2012) · Fertility and Sterility · doi:10.1016/j.fertnstert.2012.06.044 · Cited by 191 · cited 1×
“Adenomyosis is a common gynecologic disorder with poorly understood pathogenesis and pathophysiology (Bergeron et al., 2006; Benagiano et al., 2012).”
BackgroundNawshad, A., LaGamba, D., & Hay, E. D. (2004) · Archives of Oral Biology · doi:10.1016/j.archoralbio.2004.05.007 · Cited by 188 · cited 1×
“In addition, while EMT is known to occur in tissue repair (Thiery et al., 2009) and often leads to fibrosis (Nawshad et al., 2004), it is unclear whether fibrosis also is present in adenomyosis as in endometriosis (Matsuzaki and Darcha, 2013).”
BackgroundInflammation and coagulation. An overview
Petäjä, J. (2011) · Thrombosis Research · doi:10.1016/s0049-3848(10)70153-5 · Cited by 178 · cited 2×
“In fact, the two entities are now known to be intricately interconnected: inflammation activates the coagulation cascade and coagulation modulates the inflammatory activity in many ways (Lipinski et al., 2011; Petaja, 2011), as in cardiovascular disease (Demetz and Ott, 2012).”
BackgroundMedical and surgical management of adenomyosis
Farquhar, C., & Brosens, I. (2006) · Best Practice & Research Clinical Obstetrics & Gynaecology · doi:10.1016/j.bpobgyn.2006.01.012 · Cited by 170 · cited 1×
“Besides a soft and diffusely enlarged uterus, its symptoms also include dysmenorrhea, heavy menstrual bleeding, and subfertility (Farquhar and Brosens, 2006).”
BackgroundUterine peristaltic activity and the development of endometriosis
LEYENDECKER, G., KUNZ, G., HERBERTZ, M., BEIL, D., HUPPERT, P., MALL, G., KISSLER, S., NOE, M., & WILDT, L. (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1335.036 · Cited by 162 · cited 2×
“…TXA2 by activated platelets may likely promote uterine hyperperistalsis or even dysperistalsis, as documented in adenomyosis (Kunz et al., 1998; Leyendecker et al., 2004; Kissler et al., 2007), since inherently unevenly distributed adenomyotic lesions and thus uneven TXA2 concentration in the…”
BackgroundNormal ranges of angiogenesis regulatory proteins in human platelets
Peterson, J. E., Zurakowski, D., Italiano, J. E., Michel, L. V., Fox, L., Klement, G. L., & Folkman, J. (2010) · American Journal of Hematology · doi:10.1002/ajh.21732 · Cited by 160 · cited 1×
“Platelets are now regarded as the major source of VEGF in serum, as the platelet pool comprises over 80% of total circulating VEGF in patients with cancer as well as healthy individuals (Holmes et al., 2008; Peterson et al., 2010).”
BackgroundAdenomyosis—A Result of Disordered Stromal Differentiation
Parrott, E. L., Butterworth, M., Green, A. R., White, I. N. H., & Greaves, P. (2001) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)61733-6 · Cited by 154 · cited 2×
“Capitalizing on these findings and employing a mouse model of adenomyosis (Parrott et al., 2001), we conducted a mouse study that examined (through immunohistochemistry (IHC)) platelet aggregation, EMT, FMT, TGF-b1, phosphorylated Smad3 (p-Smad3), and collagen I, and the extent of fibrosis through…”
MethodSobinoff, A. P., Dando, S. J., Redgrove, K. A., Sutherland, J. M., Stanger, S. J., Armitage, C. W., Timms, P., McLaughlin, E. A., & Beagley, K. W. (2015) · Biology of Reproduction · doi:10.1095/biolreprod.114.124180 · Cited by 150
Adenomyosis: the pathophysiology of an oestrogen-dependent disease
Kitawaki, J. (2006) · Best Practice & Research Clinical Obstetrics & Gynaecology · doi:10.1016/j.bpobgyn.2006.01.010 · Cited by 143 · cited 4×
“Adenomyosis has been traditionally viewed as an estrogen-dependent disorder (Kitawaki, 2006), featuring aberrant expression of aromatase and increased production of estrogens (Kitawaki et al.”
BackgroundInfluentialShen, M. Y., Hsiao, G., Liu, C. L., Fong, T. H., Lin, K. H., Chou, D. S., & Sheu, J. R. (2007) · British Journal of Haematology · doi:10.1111/j.1365-2141.2007.06788.x · Cited by 143 · cited 1×
“…Wang et al., 2011), and quercetin (Zhang et al., 2009), turn out to be either anti-platelet or antithrombotic (Choo et al., 2002; Liu et al., 2006; Shen et al., 2007; Jin et al., 2008; Mayanglambam et al., 2010; Davidson et al., 2011; Lu et al., 2011; Lien et al., 2013; Mosawy et al., 2013a,b).”
BackgroundSelf-citationPlatelets Strongly Induce Hepatocyte Proliferation with IGF-1 and HGF In Vitro
Matsuo, R., Ohkohchi, N., Murata, S., Ikeda, O., Nakano, Y., Watanabe, M., Hisakura, K., Myronovych, A., Kubota, T., Narimatsu, H., et al. (2008) · Journal of Surgical Research · doi:10.1016/j.jss.2007.02.035 · Cited by 142 · cited 14×
“Platelets and HGF were co-localized mostly in the stromal component of adenomyotic lesions, near the glandular epithelium. limitations, reasons for caution: The results are limited by the cross-sectional natureof the studyand the use of histochemistry and immunohistochemistry analyses only, but nonetheless is a valida…”
BackgroundInfluentialDing, D., Liu, X., Duan, J., & Guo, S.-W. (2015) · Human Reproduction · doi:10.1093/humrep/dev025 · Cited by 139 · cited 5×
“commonality of being wounds that undergo repeated tissue injury and repair, resulting ultimately in fibrosis (Ding et al., 2015; Guo et al., 2015).”
BackgroundMethodResultSelf-citationMatsuzaki, S., & Darcha, C. (2013) · PLoS ONE · doi:10.1371/journal.pone.0076808 · Cited by 138 · cited 1×
“In addition, while EMT is known to occur in tissue repair (Thiery et al., 2009) and often leads to fibrosis (Nawshad et al., 2004), it is unclear whether fibrosis also is present in adenomyosis as in endometriosis (Matsuzaki and Darcha, 2013).”
BackgroundKunz, G. (1998) · Human Reproduction Update · doi:10.1093/humupd/4.5.647 · Cited by 136 · cited 2×
“, 2002), which are unaffected by hormones (Senchyna and Crankshaw, 1999), the released TXA2 by activated platelets may likely promote uterine hyperperistalsis or even dysperistalsis, as documented in adenomyosis (Kunz et al., 1998; Leyendecker et al., 2004; Kissler et al., 2007), since inherently unevenly distributed…”
BackgroundNie, J., Liu, X., & Guo, S. (2010) · Reproductive Sciences · doi:10.1177/1933719110377118 · Cited by 128
Self-citationInagaki, N., Ung, L., Otani, T., Wilkinson, D., & Lopata, A. (2003) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/s0301-2115(03)00244-6 · Cited by 126 · cited 1×
“Our finding of elevated TGF-b1 expression in adenomyosis is in broad agreement with the reported increased TGF-b1 concentration in uterine washings (Inagaki et al., 2003).”
BackgroundShen, M., Liu, X., Zhang, H., & Guo, S.-W. (2015) · Human Reproduction · doi:10.1093/humrep/dev314 · Cited by 124
Self-citationChoo, M., Park, E.-K., Yoon, H.-K., & Kim, D. (2002) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.25.1328 · Cited by 113 · cited 1×
“…2015), puerarin (Chen et al., 2011; Wang et al., 2011), and quercetin (Zhang et al., 2009), turn out to be either anti-platelet or antithrombotic (Choo et al., 2002; Liu et al., 2006; Shen et al., 2007; Jin et al., 2008; Mayanglambam et al., 2010; Davidson et al., 2011; Lu et al., 2011; Lien et…”
BackgroundFibrosis and smooth muscle metaplasia in rectovaginal endometriosis
Itoga, T., Matsumoto, T., Takeuchi, H., Yamasaki, S., Sasahara, N., Hoshi, T., & Kinoshita, K. (2003) · Pathology International · doi:10.1046/j.1440-1827.2003.01483.x · Cited by 108 · cited 2×
“However, the presence of smooth muscle metaplasia (SMM) in adenomyosis (Mechsner et al., 2010) and its documented correlation with the extent of fibrosis in endometriosis (Itoga et al., 2003) suggest that fibrosis should be present in adenomyosis.”
BackgroundInnervation of endometrium and myometrium in women with painful adenomyosis and uterine fibroids
Zhang, X., Lu, B., Huang, X., Xu, H., Zhou, C., & Lin, J. (2010) · Fertility and Sterility · doi:10.1016/j.fertnstert.2009.03.026 · Cited by 100 · cited 1×
“Moreover, platelet-derived NGF and BDNF could be responsible for myometrial hyperinnervation in adenomyosis (Zhang et al., 2010; Barcena de Arellano et al., 2011, 2013).”
BackgroundAntifibrotic properties of epigallocatechin-3-gallate in endometriosis
Matsuzaki, S., & Darcha, C. (2014) · Human Reproduction · doi:10.1093/humrep/deu123 · Cited by 100 · cited 2×
“While it has recently been shown that epigallocatechin-3-gallate (EGCG) is promising for its anti-fibrotic properties in treating endometriosis (Matsuzaki and Darcha, 2014) and also efficacious in treating adenomyosis in mice with induced adenomyosis (Chen et al.”
BackgroundLuther, T., Müller, I., & Engelmann, B. (2003) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1613535 · Cited by 97 · cited 1×
“Tissue factor plays a critical role in the initiation of platelet activation and coagulation (Engelmann et al., 2003).”
BackgroundOh, S. J., Shin, J., Kim, T. H., Lee, H. S., Yoo, J., Ahn, J. Y., Broaddus, R. R., Taketo, M. M., Lydon, J. P., Leach, R. E., et al. (2013) · The Journal of Pathology · doi:10.1002/path.4224 · Cited by 95 · cited 1×
“Oh et al. reported elevated levels of nuclear b-catenin in adenomyosis and found that stabilized b-catenin expression in mouse resulted in changed expression of EMT markers, such as E-cadherin, SNAIL and ZEB1, concomitant with increased incidence of adenomyosis (Oh et al., 2013).”
BackgroundTreatment of adenomyosis with long-term GnRH analogues: a case report.
Grow, D. R., & Filer, R. B. (1991) · PubMed · Cited by 92
Huang, T., Chen, Y., Chou, T., Chen, C., Li, H., Huang, B., Tsai, H., Lan, H., Chang, C., Twu, N., et al. (2014) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.12300 · Cited by 90 · cited 2×
“Thus, platelets may well be an important source for the increased angiogenesis seen in adenomyosis (Schindl et al., 2001; Huang et al., 2014).”
BackgroundBarcena de Arellano, M. L., Arnold, J., Vercellino, F., Chiantera, V., Schneider, A., & Mechsner, S. (2011) · Fertility and Sterility · doi:10.1016/j.fertnstert.2010.10.023 · Cited by 89 · cited 1×
“Moreover, platelet-derived NGF and BDNF could be responsible for myometrial hyperinnervation in adenomyosis (Zhang et al., 2010; Barcena de Arellano et al., 2011, 2013).”
BackgroundUtero‐Tubal Sperm Transport and Its Impairment in Endometriosis and Adenomyosis
KISSLER, S., ZANGOS, S., WIEGRATZ, I., KOHL, J., RODY, A., GAETJE, R., DOEBERT, N., WILDT, L., KUNZ, G., LEYENDECKER, G., et al. (2007) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1389.036 · Cited by 89 · cited 2×
“…may likely promote uterine hyperperistalsis or even dysperistalsis, as documented in adenomyosis (Kunz et al., 1998; Leyendecker et al., 2004; Kissler et al., 2007), since inherently unevenly distributed adenomyotic lesions and thus uneven TXA2 concentration in the uterus may disrupt…”
BackgroundLu, W., Lee, J.-J., Chou, D., Jayakumar, T., Fong, T., Hsiao, G., & Sheu, J. (2011) · Journal of Molecular Medicine · doi:10.1007/s00109-011-0800-0 · Cited by 87 · cited 1×
“…Wang et al., 2011), and quercetin (Zhang et al., 2009), turn out to be either anti-platelet or antithrombotic (Choo et al., 2002; Liu et al., 2006; Shen et al., 2007; Jin et al., 2008; Mayanglambam et al., 2010; Davidson et al., 2011; Lu et al., 2011; Lien et al., 2013; Mosawy et al., 2013a,b).”
BackgroundA pilot study on the off-label use of valproic acid to treat adenomyosis
Liu, X., & Guo, S. (2007) · Fertility and Sterility · doi:10.1016/j.fertnstert.2006.11.009 · Cited by 87 · cited 1×
“…inpreclinical and clinical studies, suchasandrographolide (Mao et al., 2011; Li et al., 2013; Liu et al., 2014), valproic acid (Liu and Guo, 2008, 2011; Liu et al., 2010), curcumin (Zhang et al., 2011), resveratrol (Zhu et al., 2015), puerarin (Chen et al., 2011; Wang et al.,…”
BackgroundSelf-citationLi, B., Chen, M., Liu, X., & Guo, S. (2013) · Fertility and Sterility · doi:10.1016/j.fertnstert.2013.04.028 · Cited by 86 · cited 3×
“…are reported to be promising in treating adenomyosisorendometriosis inpreclinical and clinical studies, suchasandrographolide (Mao et al., 2011; Li et al., 2013; Liu et al., 2014), valproic acid (Liu and Guo, 2008, 2011; Liu et al., 2010), curcumin (Zhang et al., 2011), resveratrol (Zhu et…”
BackgroundResultSelf-citationGuo, S.-W., Ding, D., Shen, M., & Liu, X. (2015) · Reproductive Sciences · doi:10.1177/1933719115570907 · Cited by 86 · cited 3×
“commonality of being wounds that undergo repeated tissue injury and repair, resulting ultimately in fibrosis (Ding et al., 2015; Guo et al., 2015).”
BackgroundSelf-citationPRL as a Novel Potent Cofactor for Platelet Aggregation
Wallaschofski, H., Donné, M., Eigenthaler, M., Hentschel, B., Faber, R., Stepan, H., Koksch, M., & Lohmann, T. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.86.12.5912 · Cited by 80 · cited 1×
“…considerable experimental data (Mori et al., 1991; Ficicioglu et al., 1995) and limited clinical data (Yu et al., 2015) support the involvement of hyperprolactinemia in adenomyosis, yet prolactin is a potent cofactor for platelet aggregation (Wallaschofski et al., 2001; Urban et al., 2007).”
BackgroundEvidence of neurotrophic events due to peritoneal endometriotic lesions
Barcena de Arellano, M. L., Arnold, J., Lang, H., Vercellino, G. F., Chiantera, V., Schneider, A., & Mechsner, S. (2013) · Cytokine · doi:10.1016/j.cyto.2013.03.003 · Cited by 78 · cited 1×
“Moreover, platelet-derived NGF and BDNF could be responsible for myometrial hyperinnervation in adenomyosis (Zhang et al., 2010; Barcena de Arellano et al., 2011, 2013).”
BackgroundMechsner, S., Grum, B., Gericke, C., Loddenkemper, C., Dudenhausen, J. W., & Ebert, A. D. (2010) · Fertility and Sterility · doi:10.1016/j.fertnstert.2010.03.015 · Cited by 74 · cited 2×
“However, the presence of smooth muscle metaplasia (SMM) in adenomyosis (Mechsner et al., 2010) and its documented correlation with the extent of fibrosis in endometriosis (Itoga et al., 2003) suggest that fibrosis should be present in adenomyosis.”
BackgroundResultLiu, X., Nie, J., & Guo, S.-W. (2011) · Human Reproduction · doi:10.1093/humrep/deq311 · Cited by 71 · cited 1×
“While increased platelet aggregation in adenomyosis has never been reported, we note that our results are nonetheless consistent with our previous report that the expression of tissue factor in adenomyosis is elevated (Liu et al., 2011; Li et al., 2013).”
ResultSelf-citationKhan, K. N., Kitajima, M., Hiraki, K., Fujishita, A., Nakashima, M., & Masuzaki, H. (2015) · Biology of Reproduction · doi:10.1095/biolreprod.114.124891 · Cited by 69 · cited 19×
“Platelets and HGF were co-localized mostly in the stromal component of adenomyotic lesions, near the glandular epithelium. limitations, reasons for caution: The results are limited by the cross-sectional natureof the studyand the use of histochemistry and immunohistochemistry analyses only, but nonetheless is a valida…”
BackgroundMethodResultInfluentialDevelopment of smooth muscle in the human fetal uterus: an ultrastructural study.
Konishi, I., Fujii, S., Okamura, H., & Mori, T. (1984) · Europe PMC (PubMed Central) · Cited by 68
Valproic Acid as a Therapy for Adenomyosis: A Comparative Case Series
Liu, X., Yuan, L., & Guo, S. (2010) · Reproductive Sciences · doi:10.1177/1933719110373807 · Cited by 68 · cited 2×
“, 2014), valproic acid (Liu and Guo, 2008, 2011; Liu et al., 2010), curcumin (Zhang et al.”
BackgroundSelf-citationMao, X., Wang, Y., Carter, A. V., Zhen, X., & Guo, S. (2011) · Reproductive Sciences · doi:10.1177/1933719111404610 · Cited by 65 · cited 2×
“In fact, some compounds that are reported to be promising in treating adenomyosisorendometriosis inpreclinical and clinical studies, suchasandrographolide (Mao et al., 2011; Li et al., 2013; Liu et al., 2014), valproic acid (Liu and Guo, 2008, 2011; Liu et al.”
BackgroundSelf-citationJin, Y.-R., Im, J.-H., Park, E.-S., Cho, M.-R., Han, X.-H., Lee, J.-J., Lim, Y., Kim, T.-J., & Yun, Y.-P. (2008) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0b013e31815ab4b6 · Cited by 65 · cited 1×
“…Wang et al., 2011), and quercetin (Zhang et al., 2009), turn out to be either anti-platelet or antithrombotic (Choo et al., 2002; Liu et al., 2006; Shen et al., 2007; Jin et al., 2008; Mayanglambam et al., 2010; Davidson et al., 2011; Lu et al., 2011; Lien et al., 2013; Mosawy et al., 2013a,b).”
BackgroundPuerarin Suppresses Invasion and Vascularization of Endometriosis Tissue Stimulated by 17β-Estradiol
Wang, D., Liu, Y., Han, J., Zai, D., Ji, M., Cheng, W., Xu, L., Yang, L., He, M., Ni, J., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0025011 · Cited by 65 · cited 1×
“…acid (Liu and Guo, 2008, 2011; Liu et al., 2010), curcumin (Zhang et al., 2011), resveratrol (Zhu et al., 2015), puerarin (Chen et al., 2011; Wang et al., 2011), and quercetin (Zhang et al., 2009), turn out to be either anti-platelet or antithrombotic (Choo et al., 2002; Liu et al., 2006;…”
BackgroundIncreased Immunoreactivity to SLIT/ROBO1 in Ovarian Endometriomas
Shen, F., Liu, X., Geng, J.-G., & Guo, S. (2009) · American Journal Of Pathology · doi:10.2353/ajpath.2009.090024 · Cited by 64 · cited 2×
“The CD31 labeled microvessel density (MVD) was counted under 400× high-power (Hp) microscopy, as reported previously (Shen et al., 2009).”
MethodSelf-citationZhang, C.-J. (2010) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2010.552 · Cited by 64 · cited 2×
“, 2010), curcumin (Zhang et al., 2011), resveratrol (Zhu et al.”
BackgroundThe Interface between Inflammation and Coagulation in Cardiovascular Disease
Demetz, G., & Ott, I. (2012) · International Journal of Inflammation · doi:10.1155/2012/860301 · Cited by 63 · cited 2×
“In fact, the two entities are now known to be intricately interconnected: inflammation activates the coagulation cascade and coagulation modulates the inflammatory activity in many ways (Lipinski et al., 2011; Petaja, 2011), as in cardiovascular disease (Demetz and Ott, 2012).”
BackgroundIncreased microvessel density in adenomyosis uteri
Schindl, M., Birner, P., Obermair, A., Kiesel, L., & Wenzl, R. J. (2001) · Fertility and Sterility · doi:10.1016/s0015-0282(00)01642-3 · Cited by 62 · cited 2×
“Thus, platelets may well be an important source for the increased angiogenesis seen in adenomyosis (Schindl et al., 2001; Huang et al., 2014).”
BackgroundExpression of smooth muscle markers in so called malignant fibrous histiocytomas
Hasegawa, T., Hasegawa, F., Hirose, T., Sano, T., & Matsuno, Y. (2003) · Journal of Clinical Pathology · doi:10.1136/jcp.56.9.666 · Cited by 62 · cited 2×
“, 2010), desmin, a marker for differentiated and mature SMC (Hasegawa et al., 2003), and SM-MHC, a marker restricted for the SMC (Manabe and Owens, 2001), in adenomyotic lesions as well as control endometrium.”
BackgroundSmooth muscle differentiation at endometrio-myometrial junction
Fujii, S., Konishi, I., & Mori, T. (1989) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/bf00718589 · Cited by 61 · cited 1×
“…https://academic.oup.com/humrep/article-abstract/31/4/734/2380144 by guest on 26 July 2018 physiological transdifferentiation of undifferentiated mesenchymal cells into myometrial SMCs in the junctional zone of the uterus has been previously established (Konishi et al., 1984; Fujii et al., 1989).”
BackgroundLipinski, S., Bremer, L., Lammers, T., Thieme, F., Schreiber, S., & Rosenstiel, P. C. (2010) · Hämostaseologie · doi:10.5482/ha-1134 · Cited by 61 · cited 2×
“In fact, the two entities are now known to be intricately interconnected: inflammation activates the coagulation cascade and coagulation modulates the inflammatory activity in many ways (Lipinski et al., 2011; Petaja, 2011), as in cardiovascular disease (Demetz and Ott, 2012).”
BackgroundAnimal model of uterine adenomyosis: Is prolactin a potent inducer of adenomyosis in mice?
Mori, T., Singtripop, T., & Kawashima, S. (1991) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(91)90258-s · Cited by 60 · cited 2×
“In addition, considerable experimental data (Mori et al., 1991; Ficicioglu et al., 1995) and limited clinical data (Yu et al.”
BackgroundManabe, I., & Owens, G. K. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m105402200 · Cited by 57 · cited 12×
“Since ectopic endometrial stromal cells are in direct contact with the underlying myometrium, which is conducive to cell–cell crosstalk and interaction, these de novo SMCs may be fused with myometrial SMCs, resulting in an enlarged uterus.”
BackgroundInfluentialSingh, V., Barbosa, F. L., Torricelli, A. A. M., Santhiago, M. R., & Wilson, S. E. (2014) · Experimental Eye Research · doi:10.1016/j.exer.2014.01.003 · Cited by 55 · cited 1×
“…(Chambers et al., 2003), markers that are thought to be reserved for differentiated SMC. Similarly, corneal fibroblasts with extended exposure to TGF-b1 and PDGF had increased expression of desmin (Singh et al., 2014), yet activated platelets are known to release PDGF (Coppinger et al., 2004).”
BackgroundValproic acid alleviates generalized hyperalgesia in mice with induced adenomyosis
Liu, X., & Guo, S. (2011) · Journal of Obstetrics and Gynaecology Research · doi:10.1111/j.1447-0756.2011.01655.x · Cited by 53 · cited 1×
“…inpreclinical and clinical studies, suchasandrographolide (Mao et al., 2011; Li et al., 2013; Liu et al., 2014), valproic acid (Liu and Guo, 2008, 2011; Liu et al., 2010), curcumin (Zhang et al., 2011), resveratrol (Zhu et al., 2015), puerarin (Chen et al., 2011; Wang et al.,…”
BackgroundSelf-citationEpigallocatechin-3-Gallate Has an Anti-Platelet Effect in a Cyclic AMP-Dependent Manner
Ok, W. J., Cho, H., Kim, H.-H., Lee, D., Kang, H., Kwon, H.-W., Rhee, M. H., Kim, M., & Park, H.-J. (2012) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.10363 · Cited by 50 · cited 2×
“, 2013, 2014), it is perhaps no coincidence that EGCG is anti-platelet (Ok et al., 2012).”
BackgroundPregnancy's Fast Flame for the Flu
Schubert, C. (2015) · Biology of Reproduction · doi:10.1095/biolreprod.114.125542 · Cited by 47
Endometriotic Implants Regress in Rat Models Treated With Puerarin by Decreasing Estradiol Level
Chen, Y., Chen, C., Shi, S., Han, J., Wang, J., Hu, J., Liu, Y., Cai, Z., & Yu, C. (2011) · Reproductive Sciences · doi:10.1177/1933719111398500 · Cited by 47 · cited 2×
“, 2015), puerarin (Chen et al., 2011; Wang et al., 2011), and quercetin (Zhang et al.”
BackgroundMayanglambam, A., Dangelmaier, C., Thomas, D., Reddy, C. D., Daniel, J. L., & Kunapuli, S. P. (2010) · Platelets · doi:10.3109/09537100903528269 · Cited by 46 · cited 1×
“…Wang et al., 2011), and quercetin (Zhang et al., 2009), turn out to be either anti-platelet or antithrombotic (Choo et al., 2002; Liu et al., 2006; Shen et al., 2007; Jin et al., 2008; Mayanglambam et al., 2010; Davidson et al., 2011; Lu et al., 2011; Lien et al., 2013; Mosawy et al., 2013a,b).”
BackgroundYu, Y., Zhang, J., Han, Z., Xia, M., Yan-li, H., Xu, C.-T., Ruifang, X., & Bing-song, Z. (2015) · Scientific Reports · doi:10.1038/srep10034 · Cited by 46 · cited 2×
“, 1995) and limited clinical data (Yu et al., 2015) support the involvement of hyperprolactinemia in adenomyosis, yet prolactin is”
BackgroundExpression of interleukin-8 and monocyte chemotactic protein-1 in adenomyosis
Ulukus, E. C., Ulukus, M., Seval, Y., Zheng, W., & Arici, A. (2005) · Human Reproduction · doi:10.1093/humrep/dei154 · Cited by 41 · cited 1×
“It is also recognized as an inflammatory disease, as characterized by increased production/expression of proinflammatory cytokines and chemokines (Ulukus et al., 2005, 2006; Benagiano et al., 2014) and the constitutive activation of nuclear factor-kB (Li et al., 2013).”
BackgroundMosawy, S., Jackson, D. E., Woodman, O. L., & Linden, M. D. (2012) · Platelets · doi:10.3109/09537104.2012.749396 · Cited by 41
Holmes, C. E., Huang, J. C.-S., Pace, T. R., Howard, A., & Muss, H. B. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-4640 · Cited by 40 · cited 1×
“Platelets are now regarded as the major source of VEGF in serum, as the platelet pool comprises over 80% of total circulating VEGF in patients with cancer as well as healthy individuals (Holmes et al., 2008; Peterson et al., 2010).”
BackgroundDavidson, D. C., Hirschman, M. P., Spinelli, S. L., Morrell, C. N., Schifitto, G., Phipps, R. P., & Maggirwar, S. B. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1001911 · Cited by 38 · cited 1×
“…Wang et al., 2011), and quercetin (Zhang et al., 2009), turn out to be either anti-platelet or antithrombotic (Choo et al., 2002; Liu et al., 2006; Shen et al., 2007; Jin et al., 2008; Mayanglambam et al., 2010; Davidson et al., 2011; Lu et al., 2011; Lien et al., 2013; Mosawy et al., 2013a,b).”
BackgroundZhu, B., Chen, Y., Zhang, H., Liu, X., & Guo, S. (2015) · Reproductive Sciences · doi:10.1177/1933719115572479 · Cited by 35 · cited 2×
“…2011; Li et al., 2013; Liu et al., 2014), valproic acid (Liu and Guo, 2008, 2011; Liu et al., 2010), curcumin (Zhang et al., 2011), resveratrol (Zhu et al., 2015), puerarin (Chen et al., 2011; Wang et al., 2011), and quercetin (Zhang et al., 2009), turn out to be either anti-platelet or…”
BackgroundSelf-citationChen, Y., Zhu, B., Zhang, H., Liu, X., & Guo, S. (2013) · Reproductive Sciences · doi:10.1177/1933719113488455 · Cited by 34 · cited 1×
“…(EGCG) is promising for its anti-fibrotic properties in treating endometriosis (Matsuzaki and Darcha, 2014) and also efficacious in treating adenomyosis in mice with induced adenomyosis (Chen et al., 2013, 2014), it is perhaps no coincidence that EGCG is anti-platelet (Ok et al., 2012).”
BackgroundSelf-citation[Histological and biochemical studies of collagen in human uterine leiomyomas].
Fujita, M. (1985) · PubMed · Cited by 34
Mosawy, S., Jackson, D. E., Woodman, O. L., & Linden, M. D. (2012) · Journal of Thrombosis and Thrombolysis · doi:10.1007/s11239-012-0827-2 · Cited by 31
Liu, R., Xing, D., Lu, H. Y., Wu, H., & Du, L. (2006) · The American Journal of Chinese Medicine · doi:10.1142/s0192415x06004508 · Cited by 31 · cited 1×
“…et al., 2011; Wang et al., 2011), and quercetin (Zhang et al., 2009), turn out to be either anti-platelet or antithrombotic (Choo et al., 2002; Liu et al., 2006; Shen et al., 2007; Jin et al., 2008; Mayanglambam et al., 2010; Davidson et al., 2011; Lu et al., 2011; Lien et al., 2013; Mosawy…”
BackgroundLien, L., Su, C., Hsu, W., Lu, W., Chung, C., Yen, T., Chiu, H., Sheu, J., & Lin, K. (2013) · Phytotherapy Research · doi:10.1002/ptr.4911 · Cited by 30 · cited 1×
“…Wang et al., 2011), and quercetin (Zhang et al., 2009), turn out to be either anti-platelet or antithrombotic (Choo et al., 2002; Liu et al., 2006; Shen et al., 2007; Jin et al., 2008; Mayanglambam et al., 2010; Davidson et al., 2011; Lu et al., 2011; Lien et al., 2013; Mosawy et al., 2013a,b).”
BackgroundCrankshaw, D. (1995) · European Journal of Pharmacology · doi:10.1016/0014-2999(95)00398-5 · Cited by 29 · cited 1×
“Second, since TXA2 is known to be an inducer of uterine hyperactivity (Wetzka et al., 1994; Crankshaw, 1995) through TXA2 receptors, TPs (Moore et al., 2002), which are unaffected by hormones (Senchyna and Crankshaw, 1999), the released TXA2 by activated platelets may likely promote uterine…”
BackgroundChen, Y., Zhu, B., Zhang, H., Ding, D., Liu, X., & Guo, S. (2014) · Reproductive Sciences · doi:10.1177/1933719113518984 · Cited by 28 · cited 1×
“…(EGCG) is promising for its anti-fibrotic properties in treating endometriosis (Matsuzaki and Darcha, 2014) and also efficacious in treating adenomyosis in mice with induced adenomyosis (Chen et al., 2013, 2014), it is perhaps no coincidence that EGCG is anti-platelet (Ok et al., 2012).”
BackgroundSelf-citationGuerrero, C. Á. H., Montenegro, L. B., Díaz, J. D. L. J., Mier‐Cabrera, J., & Valencia, P. (2006) · PubMed · Cited by 28
Oxytocin-induced cell growth proliferation in human myometrial cells and leiomyomas
Busnelli, M., Rimoldi, V., Viganò, P., Persani, L., Blasio, A. M. D., & Chini, B. (2010) · Fertility and Sterility · doi:10.1016/j.fertnstert.2009.10.064 · Cited by 27 · cited 2×
“We also stained for OTR, which is detected only in fully differentiated SMCs (Busnelli et al., 2010), desmin, a marker for differentiated and mature SMC (Hasegawa et al.”
MethodExpression of interleukin-8 receptors in patients with adenomyosis
Ulukuş, M., Ulukus, E. C., Seval, Y., Çınar, Ö., Zheng, W., & Arici, A. M. (2006) · Fertility and Sterility · doi:10.1016/j.fertnstert.2005.08.053 · Cited by 24 · cited 1×
“It is also recognized as an inflammatory disease, as characterized by increased production/expression of proinflammatory cytokines and chemokines (Ulukus et al., 2005, 2006; Benagiano et al., 2014) and the constitutive activation of nuclear factor-kB (Li et al., 2013).”
BackgroundFıçıcıoğlu, C., Tekin, H. I., Arioglu, P. F., & Okar, İ. (1995) · PubMed · Cited by 24
Immunohistochemical localization of throm☐ane synthase in human intrauterine tissues
Wetzka, B., ̈fer, W. S., Kommoss, F. K. F., Bettendorf, H., ̈sing, R. N., Breckwoldt, M., & Zahradnik, H. P. (1994) · Placenta · doi:10.1016/0143-4004(94)90006-x · Cited by 19 · cited 1×
“Second, since TXA2 is known to be an inducer of uterine hyperactivity (Wetzka et al., 1994; Crankshaw, 1995) through TXA2 receptors, TPs (Moore et al., 2002), which are unaffected by hormones (Senchyna and Crankshaw, 1999), the released TXA2 by activated platelets may likely promote uterine…”
BackgroundA pilot study on the use of andrographolide to treat symptomatic adenomyosis
Liu, X., Yu, S., & Guo, S. (2014) · Gynecology and Minimally Invasive Therapy · doi:10.1016/j.gmit.2014.12.002 · Cited by 17 · cited 2×
“In fact, some compounds that are reported to be promising in treating adenomyosisorendometriosis inpreclinical and clinical studies, suchasandrographolide (Mao et al., 2011; Li et al., 2013; Liu et al., 2014), valproic acid (Liu and Guo, 2008, 2011; Liu et al.”
BackgroundSelf-citationUterine contraction signals—Application of the linear synchronization measures
Golińska, A. K., Oczeretko, E., Swiatecka, J., Borowska, M., & LAUDAŃSKI, T. (2009) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2009.02.013 · Cited by 16 · cited 2×
“, 2007), since inherently unevenly distributed adenomyotic lesions and thus uneven TXA2 concentration in the uterus may disrupt synchronized uterine contraction (Kitlas et al., 2009), causing pain.”
BackgroundProlactin as a factor for increased platelet aggregation.
Urban, A., Masopust, J., Malý, R., Hosák, L., & Kalnická, D. (2007) · PubMed · Cited by 16
Thromboxane receptor signalling in human myometrial cells
Moore, F. P., Asbóth, G., & Bernal, A. L. (2002) · Prostaglandins & Other Lipid Mediators · doi:10.1016/s0090-6980(01)00169-1 · Cited by 15 · cited 3×
“Second, since TXA2 is known to be an inducer of uterine hyperactivity (Wetzka et al., 1994; Crankshaw, 1995) through TXA2 receptors, TPs (Moore et al., 2002), which are unaffected by hormones (Senchyna and Crankshaw, 1999), the released TXA2 by activated platelets may likely promote uterine…”
Background[Inhibition effect and mechanisms of quercetin on surgically induced endometriosis].
Zhang, X., Wang, X., Wang, H., Yang, Q., & Qie, M. (2009) · PubMed · Cited by 10
Senchyna, M., & Crankshaw, D. (1999) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0702964 · Cited by 10 · cited 1×
“…of uterine hyperactivity (Wetzka et al., 1994; Crankshaw, 1995) through TXA2 receptors, TPs (Moore et al., 2002), which are unaffected by hormones (Senchyna and Crankshaw, 1999), the released TXA2 by activated platelets may likely promote uterine hyperperistalsis or even dysperistalsis, as…”
BackgroundKawahara‐Miki, R., Matsuda, M., & Mori, T. (2003) · Life Sciences · doi:10.1016/s0024-3205(03)00350-3 · Cited by 9 · cited 1×
“In adenomyosis, some platelet adhesion molecules, such as certain integrins, are reported to be aberrantly expressed (Kawahara et al., 2003).”
Background[Immunohistochemical study of collagen type III in adenomyosis].
Ikegami, A., & Kato, J. (1992) · PubMed · Cited by 4
Cited by
Pathogenesis of uterine adenomyosis, invagination or metaplasia?
García-Solares, J., Donnez, J., Donnez, O., & Dolmans, M.-M. (2018) · Fertility and Sterility · doi:10.1016/j.fertnstert.2017.12.030 · Cited by 339
Pathogenesis of adenomyosis, an update on molecular mechanisms
Vannuccini, S., Tosti, C., Carmona, F., Huang, S. J., Chapron, C., Guo, S.-W., & Petraglia, F. (2017) · Reproductive BioMedicine Online · doi:10.1016/j.rbmo.2017.06.016 · Cited by 326
“This is consistent with the recent finding that platelets are aggregated in adenomyotic lesions (Liu et al., 2016) (Figure 2).”
Self-citationAdenomyosis: Mechanisms and Pathogenesis
Zhai, J., Vannuccini, S., Petraglia, F., & Giudice, L. C. (2020) · Seminars in Reproductive Medicine · doi:10.1055/s-0040-1716687 · Cited by 292
Chapron, C., Tosti, C., Marcellin, L., Bourdon, M., Lafay-Pillet, M.-C., Millischer, A.-E., Streuli, I., Borghese, B., Petraglia, F., & Santulli, P. (2017) · Human Reproduction · doi:10.1093/humrep/dex088 · Cited by 294
Zhang, Q., Duan, J., Liu, X., & Guo, S.-W. (2016) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2016.03.015 · Cited by 211
Self-citation
Metadata
- Authors
- Liu, X., Shen, M., Qi, Q., Zhang, H., & Guo, S.-W.
- Affiliations
- Fudan University (CN)
- Shanghai Medical College of Fudan University (CN)
- Corresponding author
- Guo, Sun-Wei
- Venue
- Human Reproduction
- Publisher
- Oxford University Press (OUP)
- Published
- 2016-02-22
- Volume
- 31
- Issue
- 4
- Pages
- 734-749
- ISSN
- 0268-1161 (ISSN-L)
- 1460-2350
- OpenAlex
- W2303031632
- Cited by
- 190
- References
- 98
- Citations by year
- 2026: 8 · 2025: 18 · 2024: 47 · 2023: 19 · 2022: 22 · 2021: 18 · 2020: 21 · 2019: 9 · 2018: 14 · 2017: 8 · 2016: 6
- FWCI
- 16.39
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Human Reproduction (publishedVersion)
- PubMed (publishedVersion)
- HighWire Press Open Archive (submittedVersion)
- Funders
- National Science Foundation of China (2013ZYJB0019)
- Shanghai Municipal Commission of Health and Family Planning
- Topics
- Health Sciences › Medicine › Reproductive Medicine › Endometriosis Research and Treatment
- Health Sciences › Medicine › Obstetrics and Gynecology › Uterine Myomas and Treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
- Keywords
- adenomyosis, platelets, epithelial-mesenchymal transition, fibroblast-to-myofibroblast transdifferentiation, TGF-β1, Smad3 phosphorylation, fibrosis, endometrium, CD42b, extracellular matrix, angiogenesis, fibrogenesis
- MeSH terms
- Adult, Blood Platelets, Cells, Cultured, Cross-Sectional Studies, Endometrium, Female, Fibroblasts, Fibrosis, Humans, Middle Aged, Myometrium, Neovascularization, Pathologic, Platelet Aggregation, Biomarkers, Cell Proliferation, Cell Transdifferentiation, Microvessels, Myofibroblasts, Epithelial-Mesenchymal Transition, Adenomyosis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.